Virus infections in immunocompromised patients: their importance and their management

Area of Science:

• Oncology
• Virology
• Immunocompromised Hosts

Background:

• Opportunistic viral infections pose a significant threat to patients undergoing medical oncology treatment.
• Immunosuppression in cancer patients increases susceptibility to viral pathogens, impacting morbidity and mortality.

Purpose of the Study:

• To investigate the incidence and types of opportunistic viral infections in adult patients admitted to a medical oncology service.
• To evaluate the efficacy and resistance patterns of acyclovir in treating and preventing these infections.

Main Methods:

• Prospective study of 156 adult patients over one year.
• Identification of viral infections, with a focus on herpes group viruses.
• Nucleic acid hybridization used to detect herpes simplex virus DNA in neural and endothelial cells.
• Antiviral susceptibility testing of viral strains to acyclovir.

Main Results:

• 35% of patients experienced viral infections; 65% of acute leukemia patients were affected.
• Herpes group viruses accounted for 79% of infections; enteric viruses were rare.
• Herpes simplex virus DNA was detected in brain cells of patients with prior infection history, suggesting reactivation.
• Acyclovir showed efficacy in therapy and prophylaxis.
• Clinical resistance to acyclovir was observed in 3 of 23 tested strains, though in vitro sensitivity remained.

Conclusions:

• Herpesviruses are the predominant opportunistic viral pathogens in this immunocompromised patient cohort.
• Reactivation of herpes simplex virus in the central nervous system is a concern in immunosuppressed oncology patients.
• Acyclovir is a valuable therapeutic and prophylactic agent, but monitoring for clinical resistance is warranted.